IMPACT TD2 UMU
IMPACT T2D is a multi-centered project for Personalized Precision Medicine coordinated by the Centre of Regulation Genomic (CRG) focused on Type 2 Diabetes.
Project Goals
Type 2 Diabetes affects almost 14% of the Spanish adult population, and is one of theleading causes of mortality and health spending. IMPACT T2D project aims at obtaining complete genomes from a unique cohort of 1,000 patients with a T2D sub-phenotype that maximizes the genetic load. The project shall define partitioned PRSs and causal rare variants and use AI tools to develop models of stratification. Finally, it will develop mechanisms to implement this knowledge in the health system.
IMPACT TD2 UMU Goals
The UMU subproject focuses on the stratification of patients using Machine Learning and Deep Learning techniques and the development of multi-criteria algorithms for DT2 therapeutic recommendations.
Researchers @ UMU
Team members from the University of Murcia.
Partners
Partners
ImPACT T2D has a multidisciplinar consortium.
- Centre of Regulation Genomic (CRG) coordinator link
- Malaga Biomedical Research Institute (IBIMA) link
- Sant Pau Hospital link
- Univerity Hospital Clinic of Barcelona link
- University Research Institute of Primary Attention (IDIAP) link
- Research Institute Germans Trias i Pujol link
- Univerity of Las Palmas de Gran Canaria link
- CIC bioGUNE link
- University of Murcia (UMU) link
- INCLIVA Research Biomedical Centerlink
- BioCruzes Bizkaia Health Research Centerlink
Funding
IMPACT-T2D-UMU (ref. PMP21/00092) is funded by the Institute of Health Carlos III (ISCII) for Personalized Precision Medicine Research Projects of the Strategic Action in Health 2017-2020, supported by the European funds of the Recovery, Transformation and Resilience Plan (Next Generation EU programme).